Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,616 full-time employees. The firm offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
根据最新的财务报表(Form-10K),Orthofix Medical Inc 的总资产为 $850,净损失为 $-92
OFIX 的关键财务比率是什么?
Orthofix Medical Inc 的流动比率是 2.12,净利 margin 为 -11.19,每股销售为 $20.75。
Orthofix Medical Inc 的收入按细分市场或地理位置如何划分?
Orthofix Medical Inc 最大收入来源是 Spinal Implants, Biologics, and Enabling Technologies,在最近的收益报告中收入为 418,789,000。就地区而言, United States 是 Orthofix Medical Inc 的主要市场,收入为 620,829,000。